Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Sales (2018 - 2025)

Dna X filings provide 8 years of Return on Sales readings, the most recent being 0.0% for Q3 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 0.0% change, with the full-year FY2024 number at 0.01%, down 1.0% from a year prior.
  • Return on Sales hit 0.0% in Q3 2025 for Dna X, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2024 to a low of 0.01% in Q1 2021.
  • Median Return on Sales over the past 5 years was 0.0% (2025), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Sales: rose 1bps in 2022 and later decreased -1bps in 2023.
  • Dna X's Return on Sales stood at 0.01% in 2021, then soared by 172bps to 0.01% in 2022, then crashed by -118bps to 0.0% in 2023, then soared by 1325bps to 0.01% in 2024, then crashed by -125bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q3 2025), 0.01% (Q2 2025), and 0.0% (Q1 2025) per Business Quant data.